GLP-1 Weight Loss Blog
Editorial articles on GLP-1 medications, pricing strategies, side effects, and FDA regulatory updates.
Browse by category
Latest
ComparisonBariatric Surgery vs GLP-1 vs Both: 2026 Decision Guide
Surgeons and obesity-medicine doctors increasingly combine bariatric procedures with GLP-1s, before or after surgery. We compare percent total weight loss, durability, costs, and who benefits from each path.
GLP-1, Birth Control, and Pregnancy: The Washout Rules
GLP-1 medications have specific contraception and pregnancy planning requirements most prescribers rush through. We cover the Wegovy washout, Mounjaro's oral contraceptive warning, and breastfeeding gaps.
Vegan and Vegetarian Eating on GLP-1: Protein Playbook
GLP-1 medications cut appetite so dramatically that plant-based eaters routinely fall short on protein. Here is how to hit 1.2-1.6 g/kg with tofu, tempeh, seitan, and legumes when nothing sounds good.
Semaglutide Microdosing: Low-Dose Protocols, Risks, Reality
Microdosing semaglutide has exploded on Reddit and TikTok as a tolerability and cost hack. We cover what off-label means here, pharmacokinetic concerns, and questions to bring to your prescriber.
GLP-1 Shortage Status in 2026: What Is Available Now
The FDA officially resolved the GLP-1 shortage in 2025, but regional availability still varies. Here is the current FDA shortage list status and what pharmacists report on the ground in 2026.
How to Inject a GLP-1 Pen: Sites, Rotation, and Common Mistakes
Most GLP-1 prescriptions ship with a pen and a leaflet but limited coaching. Here is a plain-language walkthrough of injection sites, rotation, and the mistakes that cause bruising.
Saxenda vs Wegovy: Daily vs Weekly GLP-1 Injection
Saxenda was the original GLP-1 weight-loss injection but Wegovy replaced it for most patients. Here is when liraglutide may still be the right molecule and how the two compare on trial data.
Mounjaro vs Zepbound: Same Drug, Different Indication
Mounjaro and Zepbound contain identical tirzepatide but are FDA-approved for different conditions. Here is what that means for insurance, pricing, and prescriber decisions.
Tirzepatide vs Semaglutide: Mechanism, Results, and Side Effects
Tirzepatide and semaglutide are the two dominant GLP-1 classes but work differently. Here is what SURMOUNT, STEP, and SURPASS data show about efficacy and tolerability.
Cash Pay vs Compounded GLP-1: Which Is Cheaper in 2026?
After the FDA shortage ended, branded self-pay prices dropped while compounded options narrowed. Here is the cost math between LillyDirect, NovoCare, and remaining compounded routes.
GLP-1 Manufacturer Savings Cards in 2026: Eligibility and Limits
Savings cards advertise $25 monthly prices, but eligibility carve-outs exclude most patients. Here is what each manufacturer card actually covers in 2026.
Sulfur Burps on GLP-1: Why They Happen and How to Reduce Them
Sulfur burps are one of the most viral GLP-1 complaints on TikTok and Reddit. Here is the digestive mechanism behind the rotten-egg smell, why delayed gastric emptying makes it worse, and the dietary patterns associated with relief.
GLP-1 Hair Loss: Why It Happens and What Helps
Hair shedding is one of the most-searched GLP-1 side effects, but it is rarely caused by the drug itself. Here is the mechanism, the timeline, and what dermatologists tell patients.
GLP-1 Side Effects Week by Week: A 12-Week Timeline
Most GLP-1 side effects follow a predictable arc tied to dose escalation. Here is what patients commonly report each week and when symptoms typically peak.
How to Switch from Ozempic to Wegovy: A Patient Guide
Both Ozempic and Wegovy are semaglutide, but FDA-approved for different conditions. Here is exactly how to switch — clinically, administratively, and practically.
Wegovy Cost Without Insurance: A 2026 Guide
Wegovy retails near $1,349/month without insurance. But several legitimate channels reduce the cost to $200-400/month. Here is a complete breakdown of your options in 2026.
Compounded Semaglutide in 2026: What the FDA Crackdown Means for You
In March 2026, the FDA sent warning letters to dozens of telehealth providers marketing compounded GLP-1 medications. This explainer covers what changed, why, and what your options are now.
Ozempic Face: Causes, Prevention, and How to Manage
"Ozempic face" refers to facial volume loss seen in some patients during GLP-1 weight loss. It is not a side effect of the drug itself, but a consequence of rapid fat loss. Here is what to know.
GLP-1 Weight Loss Timeline: Realistic Results Month by Month
Clinical trial data shows where you are likely to be at each stage of GLP-1 weight loss treatment. Here is a month-by-month timeline of realistic expectations.